About LIQOMICS
We are an innovative diagnostics company specializing in the development and execution of high-precision liquid biopsy tests.
Our Story
LIQOMICS was founded in 2021. Based on years of research in liquid biopsy and ctDNA analytics, we have set ourselves the goal of revolutionizing cancer diagnostics and monitoring.
Our interdisciplinary team of scientists, physicians, and bioinformaticians works daily to push the boundaries of what's possible in non-invasive cancer diagnostics. Using state-of-the-art sequencing technology and innovative bioinformatics methods, we develop tests that can save lives.
Today, we are proud to collaborate with leading clinics and research institutions, enabling patients worldwide to access precise MRD diagnostics.
Our Values
Innovation
State-of-the-art technologies and continuous development of new approaches in ctDNA diagnostics
Patient Focus
Improving treatment and quality of life for cancer patients through precise diagnostics
Quality
Highest quality standards and precision as the foundation of our diagnostic tests
Our Team
Experienced experts from science and medicine
